
Shree Govardhan Pharma Private Limited
About Shree Govardhan Pharma Private Limited
Data last updated:
Shree Govardhan Pharma Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U36900RJ2018PTC062825. Its GSTIN is 08ABBCS0551R1ZY (Rajasthan). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Bholashankar Prajapati and Reena Kumari Prajapati.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 66 Shri Niwas Nagar Road No.6 Vki Area, Jaipur, Rajasthan, India – 302039.
As per the financials filed for FY 2025, the company reported a revenue of ₹25.75 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.17 Lakh (net margin 4.5%) and EBITDA of ₹1.36 Lakh (EBITDA margin 5.3%). Revenue has grown at a compounded annual rate (CAGR) of 82% over three years and 10% over five years.
Company details
Contact details
Shree Govardhan Pharma Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 66 Shri Niwas Nagar Road No.6 Vki Area, Jaipur, Rajasthan, India – 302039
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Shree Govardhan Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Shree Govardhan Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Shree Govardhan Pharma Private Limited, buy the company report.
Financials of Shree Govardhan Pharma Private Limited
FY 2025 filings availableShree Govardhan Pharma Private Limited reported revenue of ₹25.75 Lakh (up 774% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 774% growth in the latest year. EBITDA rose 171% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.36 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.17 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.3% | ||||
| Net Profit Margin | 4.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shree Govardhan Pharma Private Limited, buy the company report.
Board of directors of Shree Govardhan Pharma Private Limited
Shree Govardhan Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bholashankar Prajapati | Director | 25 Oct 2018 | 8 Years 0 Months | Current |
| Reena Kumari Prajapati | Additional Director | 07 Apr 2025 | 1 Years 7 Months | Current |
Peer comparison
Shree Govardhan Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Filbs Nutra Private Limited | ₹25.79 Lakh (FY 2018) | -14.0% | Udaipur, Rajasthan, India | |||
| Shree Govardhan Pharma Private Limitedthis company | ₹25.75 Lakh (FY 2025) | ₹1.17 Lakh | 4.5% | 774.0% | Jaipur, Rajasthan, India | |
| Austin Lifesciences Private Limited | ₹25.74 Lakh (FY 2022) | -48.0% | Pune, Maharashtra, India | |||
| Ventas Pharmaceuticals Private Limited | ₹25.71 Lakh (FY 2024) | 49.0% | Delhi, India | |||
| Aras Remedies Private Limited | ₹25.63 Lakh (FY 2025) | 30.0% | Anand, Gujarat, India |
To see the full peer comparison of Shree Govardhan Pharma Private Limited, buy the company report.
Auditor
Shree Govardhan Pharma Private Limited is audited by M V JAIN & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M V JAIN & ASSOCIATES | FY 2019 | 013777C |
Shareholding
The shareholding of Shree Govardhan Pharma Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Shree Govardhan Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Shree Govardhan Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shree Govardhan Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Shree Govardhan Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08ABBCS0551R1ZY | Rajasthan | Active | 13 Dec 2018 |
To see the full GST registrations and return filing status of Shree Govardhan Pharma Private Limited, buy the company report.
Recent activity
Shree Govardhan Pharma Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Ramjas Burdak ceased to be Director on 07 Apr 2025.
Frequently asked questions
Shree Govardhan Pharma is an active private limited company based in Jaipur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 October 2018 (8+ years old) and is registered under CIN U36900RJ2018PTC062825.
Shree Govardhan Pharma has 2 current directors:
- Bholashankar Prajapati - Director
- Reena Kumari Prajapati - Additional Director
The latest financial statements of Shree Govardhan Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Shree Govardhan Pharma is 08ABBCS0551R1ZY, registered in Rajasthan. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Shree Govardhan Pharma is U36900RJ2018PTC062825. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shree Govardhan Pharma was incorporated on 25 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Shree Govardhan Pharma by revenue are Filbs Nutra Private Limited, Austin Lifesciences Private Limited, Ventas Pharmaceuticals Private Limited, Aras Remedies Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ramjas Burdak ceased to be Director on 07 Apr 2025. Reena Kumari Prajapati was appointed as Additional Director on 07 Apr 2025. Priya Anand ceased to be Additional Director on 15 Apr 2020. Shree Govardhan Pharma has 4 board changes on record in total.
The registered office of Shree Govardhan Pharma is at B – 66 Shri Niwas Nagar Road No.6 Vki Area, Jaipur, Rajasthan, India – 302039.
Shree Govardhan Pharma operates in the pharma industry, in the drug formulation and development segment.
Shree Govardhan Pharma can be reached at its registered office: B – 66 Shri Niwas Nagar Road No.6 Vki Area, Jaipur, Rajasthan, India – 302039.

